Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1998-05-13
2000-09-26
Williamson, Michael A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
424468, 424474, 424475, 424479, 424480, 424484, 424486, A01N 3744
Patent
active
061243558
ABSTRACT:
A composition comprising oxybutynin, a dosage form comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.
REFERENCES:
patent: 2799241 (1957-07-01), Wurster et al.
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4063064 (1977-12-01), Saunders et al.
patent: 4088864 (1978-05-01), Theeuwes et al.
patent: 4111202 (1978-09-01), Theeuwes et al.
patent: 4200098 (1980-04-01), Ayer et al.
patent: 4285987 (1981-08-01), Ayer et al.
patent: 4327725 (1982-05-01), Cortese et al.
patent: 4612008 (1986-09-01), Wong et al.
patent: 4783337 (1988-11-01), Wong et al.
patent: 4816263 (1989-03-01), Ayer et al.
patent: 4824675 (1989-04-01), Wong et al.
patent: 4863456 (1989-09-01), Stephens et al.
patent: 4902514 (1990-02-01), Barclay et al.
patent: 5399359 (1995-03-01), Baichwal
patent: 5674895 (1997-10-01), Guittard et al.
patent: 5840754 (1998-11-01), Guittard et al.
patent: 5912268 (1999-06-01), Guittard et al.
Grafton, P., "General Principles for Designing with Plastics" Modern Plastics Encyclopedia, vol. 46, pp. 62-71 (1969-70).
Remington's Pharmaceutical Sciences, 14th Ed., pp. 1626-1680 (1970).
Wurster, Dale E., "Air-Suspension Technique of Coating Drug Particles" J. Am. Phar. Assoc. Sci. Ed., vol. 48, pp. 451-454 (Aug. 1959).
Wurster, Dale E., "Preparation of Compressed Tablet Granulations by the Air-Suspension Technique II" J. Am. Phar. Assoc., vol. 49, No. 2, pp. 82-84 (Feb. 1960).
Chemical Abstracts, vol. 120; No. 18, May 2, 1994, Abstract No. 227011.
Chemical Abstracts, vol. 120; No. 14, Apr. 4, 1994, Abstracts No. 173499.
International Journal of Pharmaceutics; 62 (1990); pp. 143-151.
USP XXI/NF XVII (1990), The United States Pharmacopeia / The National Formulary; pp. 1578-1579.
USP 23--Test Solutions; pp. 2052-2053.
Remington's Pharmaceutical Sciences (1985); 17th Ed., Chapter 35; pp. 653-666.
USP 23 / NF 18 (1995); The United States Pharmacopeia / The National Formulary; pp. 1791-1796.
Handbook of Common Polymers, by Scott/Roff (1971); pp. 79-81.
Guittard George V.
Gumucio Fernando E.
Jao Francisco
Kidney David J.
Marks Susan M.
Sabatine Paul L.
Stone Steven F.
Williamson Michael A.
LandOfFree
Oxybutynin therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxybutynin therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxybutynin therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2100752